These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3373482)

  • 21. Computer-aided insights into receptor-ligand interaction for novel 5-arylhydantoin derivatives as serotonin 5-HT
    Kucwaj-Brysz K; Kurczab R; Jastrzębska-Więsek M; Żesławska E; Satała G; Nitek W; Partyka A; Siwek A; Jankowska A; Wesołowska A; Kieć-Kononowicz K; Handzlik J
    Eur J Med Chem; 2018 Mar; 147():102-114. PubMed ID: 29425815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists.
    Millan MJ; Rivet JM; Canton H; Le Marouille-Girardon S; Gobert A
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1364-76. PubMed ID: 8450471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of 5-HT1A receptor-mediated [35S]GTPgammaS binding in rat hippocampal membranes.
    Alper RH; Nelson DL
    Eur J Pharmacol; 1998 Feb; 343(2-3):303-12. PubMed ID: 9570480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New methoxy-chroman derivatives, 4[N-(5-methoxy-chroman-3-yl)N- propylamino]butyl-8-azaspiro-(4,5)-decane-7,9-dione [(+/-)-S 20244] and its enantiomers, (+)-S 20499 and (-)-S 20500, with potent agonist properties at central 5-hydroxytryptamine1A receptors.
    Kidd EJ; Haj-Dahmane S; Jolas T; Lanfumey L; Fattaccini CM; Guardiola-Lemaitre B; Gozlan H; Hamon M
    J Pharmacol Exp Ther; 1993 Feb; 264(2):863-72. PubMed ID: 8094756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The computer-aided discovery of novel family of the 5-HT
    Łażewska D; Kurczab R; Więcek M; Kamińska K; Satała G; Jastrzębska-Więsek M; Partyka A; Bojarski AJ; Wesołowska A; Kieć-Kononowicz K; Handzlik J
    Eur J Med Chem; 2017 Jul; 135():117-124. PubMed ID: 28441580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thiazole as a carbonyl bioisostere. A novel class of highly potent and selective 5-HT3 receptor antagonists.
    Rosen T; Nagel AA; Rizzi JP; Ives JL; Daffeh JB; Ganong AH; Guarino K; Heym J; McLean S; Nowakowski JT
    J Med Chem; 1990 Oct; 33(10):2715-20. PubMed ID: 2213824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis, 5-HT1A and 5-HT2A receptor activity of new 1-phenylpiperazinylpropyl derivatives with arylalkyl substituents in position 7 of purine-2,6-dione.
    Chloń G; Pawłowski M; Duszyńska B; Szaro A; Tatarczńska E; Kłodzińska AL; Chojnacka-Wójcik E
    Pol J Pharmacol; 2001; 53(4):359-68. PubMed ID: 11990082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonists.
    Millan MJ; Canton H; Gobert A; Lejeune F; Rivet JM; Bervoets K; Brocco M; Widdowson P; Mennini T; Audinot V
    J Pharmacol Exp Ther; 1994 Jan; 268(1):337-52. PubMed ID: 8301575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigations on the 1-(2-biphenyl)piperazine motif: identification of new potent and selective ligands for the serotonin(7) (5-HT(7)) receptor with agonist or antagonist action in vitro or ex vivo.
    Lacivita E; Patarnello D; Stroth N; Caroli A; Niso M; Contino M; De Giorgio P; Di Pilato P; Colabufo NA; Berardi F; Perrone R; Svenningsson P; Hedlund PB; Leopoldo M
    J Med Chem; 2012 Jul; 55(14):6375-80. PubMed ID: 22738316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-activity relationship studies of CNS agents. Part 24: New analogs of N-tert.-butyl-3-[4-(2-methoxyphenyl)-1-piperazinyl]-2-phenylpropanamide (WAY-100135).
    Boksa J; Klodzińska A; Charakchieva-Minol S; Chojnacka-Wójcik E; Mokrosz JL
    Pharmazie; 1996 Feb; 51(2):72-6. PubMed ID: 8720802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 1,4-Benzoxazin-3(4H)-one derivatives and related compounds as 5-HT1A and 5-HT2A receptor ligands; the effect of the terminal amide fragment on the 5-HT1A/5-HT2A affinity and functional activity.
    Mokrosz MJ; Kowalski P; Kowalska T; Majka Z; Duszyńska B; Charakchieva-Minol S; Szaro A; Tatarczyńska E; Kłodzińska A; Chojnacka-Wójcik E
    Pol J Pharmacol; 1998; 50(4-5):333-40. PubMed ID: 10091718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effects of WAY-100135 on the decrease in 5-hydroxytryptamine release induced by buspirone and NAN-190.
    Routledge C; Gurling J; Ashworth-Preece MA; Dourish CT
    Eur J Pharmacol; 1995 Apr; 276(3):281-4. PubMed ID: 7601215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635.
    de Boer SF; Lesourd M; Mocaer E; Koolhaas JM
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1125-33. PubMed ID: 10027850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 5-HT1A receptor activation and antidepressant-like effects: F 13714 has high efficacy and marked antidepressant potential.
    Koek W; Vacher B; Cosi C; Assié MB; Patoiseau JF; Pauwels PJ; Colpaert FC
    Eur J Pharmacol; 2001 May; 420(2-3):103-12. PubMed ID: 11408031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 1-Thia-4,7-diaza-spiro[4.4]nonane-3,6-dione: a structural motif for 5-hydroxytryptamine 6 receptor antagonism.
    Hostetler G; Dunn D; McKenna BA; Kopec K; Chatterjee S
    Chem Biol Drug Des; 2014 Feb; 83(2):149-53. PubMed ID: 24119217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
    Schreiber R; Brocco M; Audinot V; Gobert A; Veiga S; Millan MJ
    J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5-HT1A receptor activation and anti-cataleptic effects: high-efficacy agonists maximally inhibit haloperidol-induced catalepsy.
    Prinssen EP; Colpaert FC; Koek W
    Eur J Pharmacol; 2002 Oct; 453(2-3):217-21. PubMed ID: 12398907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel 2-aminotetralin and 3-aminochroman derivatives as selective serotonin 5-HT7 receptor agonists and antagonists.
    Holmberg P; Sohn D; Leideborg R; Caldirola P; Zlatoidsky P; Hanson S; Mohell N; Rosqvist S; Nordvall G; Johansson AM; Johansson R
    J Med Chem; 2004 Jul; 47(16):3927-30. PubMed ID: 15267230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural determinants of 5-HT1A versus 5-HT1D receptor binding site selectivity.
    Harrington MA; Sleight AJ; Pitha J; Peroutka SJ
    Eur J Pharmacol; 1991 Feb; 194(1):83-90. PubMed ID: 2060596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of new serotonin 5-HT7 receptor ligands. Determinants of 5-HT7/5-HT1A receptor selectivity.
    Medina RA; Sallander J; Benhamú B; Porras E; Campillo M; Pardo L; López-Rodríguez ML
    J Med Chem; 2009 Apr; 52(8):2384-92. PubMed ID: 19326916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.